We determined the ability of self-complementary adeno-associated virus (scAAV) vectors to deliver and express the pyruvate dehydrogenase E1
![]()
www.sciencedirect.com/scidirimg/entities/204e.gif"" alt=""greek small letter alpha"" title=""greek small letter alpha"" border=""0""> subunit gene (PDHA1) in primary cultures of skin fibroblasts from 3 patients
with defined mutations in PHDA1 and 3 healthy subjects. Cells
were transduced
with scAAV vectors containing the cytomegalovirus promoter-driven enhanced green fluorescent protein (EGFP) reporter gene at a vector:cell ratio of 200. Transgene expression
was measured 72 h later. The transduction efficiency of scAAV2 and scAAV6 vectors
was 3- to 5-fold higher than that of the other serotypes,
which
were subsequently used to transduce fibroblasts
with
wild-type PDHA1 cDNA under the control of the chicken beta-action (CBA) promoter at a vector:cell ratio of 1000. Total PDH-specific activity and E1
![]()
www.sciencedirect.com/scidirimg/entities/204e.gif"" alt=""greek small letter alpha"" title=""greek small letter alpha"" border=""0""> protein expression
were determined 10 days post-transduction. Both vectors increased E1
![]()
www.sciencedirect.com/scidirimg/entities/204e.gif"" alt=""greek small letter alpha"" title=""greek small letter alpha"" border=""0""> expression 40–60 % in both control and patient cells, and increased PDH activity in t
wo patient cell lines. We also used dichloroacetate (DCA) to maximally activate PDH through dephosphorylation of E1
![]()
www.sciencedirect.com/scidirimg/entities/204e.gif"" alt=""greek small letter alpha"" title=""greek small letter alpha"" border=""0"">. Exposure for 24 h to 5 mM DCA increased PDH activity in non-transduced control (mean 37 % increase) and PDH deficient (mean 44 % increase) cells. Exposure of transduced patient fibroblasts to DCA increased PDH activity up to 90 % of the activity measured in untreated control cells. DCA also increased expression of E1
![]()
www.sciencedirect.com/scidirimg/entities/204e.gif"" alt=""greek small letter alpha"" title=""greek small letter alpha"" border=""0""> protein and, to variable extents, that of other components of the PDH complex in both non-transduced and transduced cells. These data suggest that a combined gene delivery and pharmacological approach may hold promise for the treatment of PDH deficiency.